TCL Archive Obama’s First Budget Proposes $6 Billion For Cancer Research As Step To Doubling February 27, 2009
TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer. November 2, 2007
TCL Archive NIH Review Division Considering Proposal For Clinical Oncology Study Section October 10, 1997
